Felix Biotechnology, Inc. – Trademark Portfolio
Entity Type: 03
Felix Biotechnology, Inc. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 1 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include FELIX BIOTECHNOLOGY. The owner is based in San Francisco, CA.
1160 Battery Street, Suite 100
San Francisco, CA 94109
Showing of trademarks Trademarks
Trademark Classifications
Felix Biotechnology, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Felix Biotechnology, Inc. have?
Felix Biotechnology, Inc. has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned.
What trademark classes does Felix Biotechnology, Inc. file in?
Felix Biotechnology, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 5 (Pharmaceuticals). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Felix Biotechnology, Inc.'s most well-known trademarks?
Felix Biotechnology, Inc.'s registered trademark portfolio includes well-known marks such as FELIX BIOTECHNOLOGY. These are among 1 currently registered trademark in the portfolio.
What is Felix Biotechnology, Inc.'s trademark registration success rate?
Felix Biotechnology, Inc. has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.